Search

everythinglearnresearchcommunity

for

Search:↓

Genes play a significant role in male-pattern baldness, and understanding them could lead to new treatments and insights into related health issues.

Finasteride 5 mg/day effectively treats hair loss in postmenopausal women without hyper-androgenism.

Female pattern hair loss has unclear causes, possibly involving genetics, hormones, and environment, and needs better treatments.

Melanocyte precursors in human fetal skin follow a specific migration pattern and some remain in the skin's deeper layers.

Hair transplanting is a useful, often overlooked treatment for female pattern hair loss.

Flutamide effectively treats female pattern hair loss with low doses showing good liver tolerance.

A specific genetic mutation may increase male pattern baldness risk, especially in Europeans.

Dutasteride-containing mesotherapy effectively treats female hair loss, improving density and thickness with minimal side effects.

Minoxidil helps regrow hair in female pattern hair loss, but more research needed for other treatments.

Current treatments for male pattern baldness include minoxidil and finasteride, with new options being developed.

Dutasteride helps slow hair loss and boosts hair growth.

Higher BMI links to worse hair loss in Taiwanese men.

Men who experienced baldness at age 20 may have double the risk of getting prostate cancer.

Finasteride effectively improves hair growth and slows hair loss in men with male pattern baldness.

Genetic data can predict male-pattern baldness with moderate accuracy, especially for early-onset cases in some European men.

Hair loss affects quality of life, self-esteem, and confidence, but younger patients cope better.

Combination of 0.25% finasteride and 3% minoxidil works better than just 3% minoxidil for increasing hair thickness in women.

Use finasteride, dutasteride, and minoxidil for hair loss treatment.

Female pattern hair loss involves hormonal factors, genetics, and may be linked to low ferritin levels.

Minoxidil effectively treats female pattern hair loss.

Finasteride significantly improves hair growth but may cause sexual side effects.

Combining low-level light therapy and minoxidil 5% is more effective for female hair loss than using either treatment alone.

Polarized dermoscopy is slightly better than nonpolarized for diagnosing hair disorders, with each method having its own strengths.

Growth factors and microneedle therapy increase hair density in women with hair loss.

FPHL common in Taiwanese women; risk factors include BMI, high glucose, early puberty, fewer childbirths, oral contraceptives, and UV exposure.

Finasteride shows promise for female hair loss, but more research needed.

Certain microRNAs are more common in balding areas and might be involved in male pattern baldness.

Men with baldness at the front and top of their head at age 45 may have a higher risk of aggressive prostate cancer.

Genetics affect early female hair loss, severity depends on duration, and low ferritin levels not significant.

Finasteride and dutasteride reduce unwanted movements from Parkinson's disease treatment by normalizing certain brain signals.